Compare Manhattan Associates Inc (MANH) vs 22nd Century Group Inc (XXII) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Manhattan Associates Inc vs 22nd Century Group Inc — how do they compare? Manhattan Associates Inc trades at $149.2 (market cap $9.41B), while 22nd Century Group Inc trades at $4.26 (market cap $1.56M). The key difference: Manhattan Associates Inc is far larger — about 6032.1× 22nd Century Group Inc's market cap, and Manhattan Associates Inc is trading nearer its 52-week high, 22nd Century Group Inc nearer its low. Which is the better fit depends on your goals.
| MANH | XXII | |
|---|---|---|
Market Cap | $9.41B | $1.56M |
Sector | Technology | Technology |
52-Week High | $227.94 | $999.00 |
52-Week Low | $120.88 | $3.90 |
Enterprise Value | $9.24B | -$6.67M |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Manhattan Associates (MANH) trades at $165.51, up 1.42% today, with strong technical momentum and bullish moving averages. The company shows robust profitability with a 19.68% net income margin and has beaten EPS estimates for three consecutive quarters. However, valuation ratios like a P/E of 46.37 suggest premium pricing. Recent news highlights an ongoing legal investigation into fiduciary duties by directors, while analyst consensus remains strongly positive with a $192.80 price target.
The outlook for MANH is cautiously optimistic, driven by consistent earnings beats and solid cash flow generation. Key opportunities include sustained cloud and AI adoption, but risks involve high valuation multiples, competitive pressures, and potential legal overhangs from the Rosen Law Firm investigation. Investors should weigh strong fundamentals against elevated price levels and external uncertainties.
XXII trades at $4.32, down 0.23% on the day, with neutral technical signals and bearish moving averages. The company shows significant financial challenges with negative profit margins (-65.76% net income margin) and declining revenue, though analyst sentiment remains positive with 75% buy ratings. Recent corporate actions include a 20:1 reverse stock split completed in June 2026, while expansion initiatives in California and New York aim to drive VLN brand growth.
The outlook remains speculative with high execution risk given persistent losses and negative ROE (-130.19%). Investment opportunity hinges on successful commercialization of reduced-nicotine products and FDA regulatory progress, but substantial financial deterioration and competitive pressures present significant downside risk for shareholders.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Manhattan Associates Inc
Manhattan Associates, Inc. is a global leader in supply chain and omnichannel commerce software. The company provides a comprehensive suite of cloud-based and on-premise solutions for warehouse management (WMS), transportation management (TMS), and order management (OMS). MANH's technology helps retailers, wholesalers, and manufacturers manage inventory, optimize logistics, and unify the shopping experience across physical and digital channels.
Read more on MANH →About 22nd Century Group Inc
22nd Century Group is a plant biotechnology company that uses genetic engineering and gene editing to control the levels of nicotine in tobacco plants. Its flagship product line, VLN®, is the first and only combustible cigarette authorized by the FDA as a Modified Risk Tobacco Product (MRTP), containing 95% less nicotine than traditional cigarettes to help adult smokers smoke less.
Read more on XXII →
